Susquehanna International Group’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,400
Closed -$203K 14086
2022
Q4
$203K Sell
9,400
-54,600
-85% -$1.15M ﹤0.01% 10089
2022
Q3
$1.24M Buy
64,000
+49,800
+351% +$1.03M ﹤0.01% 6083
2022
Q2
$282K Buy
14,200
+6,800
+92% +$179K ﹤0.01% 9739
2022
Q1
$221K Sell
7,400
-6,000
-45% -$176K ﹤0.01% 11006
2021
Q4
$312K Sell
13,400
-54,400
-80% -$1.45M ﹤0.01% 10402
2021
Q3
$2.12M Buy
67,800
+27,800
+70% +$860K ﹤0.01% 5706
2021
Q2
$1.41M Sell
40,000
-3,000
-7% -$97.5K ﹤0.01% 6832
2021
Q1
$1.52M Sell
43,000
-600
-1% -$22.2K ﹤0.01% 6613
2020
Q4
$1.64M Sell
43,600
-474,700
-92% -$17.3M ﹤0.01% 5539
2020
Q3
$17.3M Buy
518,300
+485,400
+1,475% +$14.1M ﹤0.01% 1617
2020
Q2
$872K Buy
32,900
+21,200
+181% +$500K ﹤0.01% 6221
2020
Q1
$192K Buy
+11,700
New +$257K ﹤0.01% 8746
2019
Q4
Sell
-14,700
Closed -$294K 10937
2019
Q3
$294K Buy
+14,700
New +$381K ﹤0.01% 8346
2019
Q2
Sell
-9,800
Closed -$316K 11040
2019
Q1
$316K Buy
+9,800
New +$264K ﹤0.01% 7123
2016
Q1
Sell
-633
Closed -$7K 9867
2015
Q4
$7K Sell
633
-24
-4% -$248 ﹤0.01% 9310
2015
Q3
$9K Sell
657
-66
-9% -$1.66K ﹤0.01% 9548
2015
Q2
$22K Sell
723
-34
-4% -$1.14K ﹤0.01% 9992
2015
Q1
$27K Sell
757
-276
-27% -$11.6K ﹤0.01% 9243
2014
Q4
$41K Buy
1,033
+6
+0.6% +$263 ﹤0.01% 9398
2014
Q3
$51K Buy
1,027
+127
+14% +$7.3K ﹤0.01% 9219
2014
Q2
$58K Sell
900
-1,127
-56% -$78.4K ﹤0.01% 9569
2014
Q1
$166K Buy
2,027
+700
+53% +$63.7K ﹤0.01% 8361
2013
Q4
$91K Sell
1,327
-1,743
-57% -$128K ﹤0.01% 8667
2013
Q3
$290K Buy
+3,070
New +$400K ﹤0.01% 7261

Other funds holding ALBO

Susquehanna International Group's ALBO Position: Q4 2022 in Review

Susquehanna International Group sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 36,525 shares — an estimated $772K sold.

Susquehanna International Group first reported a position in ALBO in Q2 2013 and held it in 23 quarters. The position peaked at $3.25M in Q2 2021. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • Susquehanna International Group reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 36,525 Albireo Pharma Inc shares in Q4 2022, an estimated $772K.
  • Susquehanna International Group first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 23 quarters.
  • Susquehanna International Group's Albireo Pharma Inc position peaked at $3.25M in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.